Definitive Healthcare Corp. (NASDAQ:DH) Receives Consensus Rating of "Hold" from Brokerages

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has earned an average recommendation of "Hold" from the eleven ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $5.81.

DH has been the topic of a number of research analyst reports. BTIG Research initiated coverage on Definitive Healthcare in a report on Tuesday, September 17th. They set a "buy" rating and a $7.00 target price on the stock. Morgan Stanley lowered their price objective on Definitive Healthcare from $9.00 to $5.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 6th. Robert W. Baird decreased their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Wednesday, August 7th. Barclays dropped their price objective on shares of Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating on the stock in a research note on Wednesday, August 7th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a research note on Friday, November 8th.

Definitive Healthcare Trading Down 0.9 %

NASDAQ DH opened at $4.63 on Wednesday. The stock has a market cap of $534.86 million, a P/E ratio of -1.51, a price-to-earnings-growth ratio of 3.50 and a beta of 1.40. Definitive Healthcare has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The stock has a 50 day simple moving average of $4.37 and a two-hundred day simple moving average of $4.77. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Point72 DIFC Ltd raised its stake in shares of Definitive Healthcare by 759.9% in the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after buying an additional 8,215 shares during the period. Intech Investment Management LLC bought a new stake in Definitive Healthcare during the 3rd quarter worth approximately $55,000. Bleakley Financial Group LLC purchased a new position in Definitive Healthcare during the third quarter valued at approximately $74,000. Glenmede Trust Co. NA lifted its holdings in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock valued at $82,000 after purchasing an additional 5,362 shares in the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Definitive Healthcare in the third quarter worth approximately $84,000. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.